Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

The findings suggest that "supportive care and management of geriatric vulnerabilities at baseline may improve outcomes and ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

A man whose father, brother and sister died “in dreadful circumstances” has told MPs their sympathy “only goes so far” as he urged them to get on with the process to legalise assisted dying.

Ajay Goel, PhD, AGAF, discusses how the development and validation of novel non-invasive biomarkers can improve early detection and ultimately impact patient outcomes for patients.

Baseline geriatric vulnerabilities and QOL scores are associated with survival after chemotherapy in older adults with metastatic pancreatic cancer, researchers found.

Youngsters, parents and staff of Sunflowers Too day nursery, in Hessle, are gearing up for a sponsored walk, toddle and ...

Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.

The UK-based Medical Detection Dogs Charity has started a groundbreaking 2025 study, training dogs to sniff out early-stage ...